Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
JAMA Internal Medicine (2021) - Comments
doi: 10.1001/jamainternmed.2020.6615  issn: 2168-6106  pubmed: 33080005  issn: 2168-6114 

Carlo Salvarani, Giovanni Dolci, Marco Massari, Domenico Franco Merlo, Silvio Cavuto, Luisa Savoldi, Paolo Bruzzi, Fabrizio Boni, Luca Braglia, Caterina Turrà, Pier Ferruccio Ballerini, Roberto Sciascia, Lorenzo Zammarchi, Ombretta Para, Pier Giorgio Scotton, Walter Omar Inojosa, Viviana Ravagnani, Nicola Duccio Salerno, Pier Paolo Sainaghi, Alessandro Brignone